No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Will Tenax Therapeutics (NASDAQ:TENX) Spend Its Cash Wisely?
Tenax Therapeutics Appoints Interim CFO Thomas McGauley
Express News | Tenax Therapeutics Inc - Appoints Thomas a. Mcgauley as Interim CFO
Roth MKM Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Maintains Target Price $30
Roth MKM Sticks to Their Buy Rating for Tenax Therapeutics (TENX)
Tenax Therapeutics | 10-Q: Q3 2024 Earnings Report
No Data